5 stories mentioning ASX:ADOUpdated 19d ago
Every FINWIRES story that references ASX:ADO, newest first.
AnteoTech (ASX:ADO) appointed Scott Waddell as chief financial officer on a fixed-term contract until Dec. 16, 2028, according to a Friday filing with the Australian bourse.Waddell has been serving as the company's interim CFO since Feb. 2, and previously held the CFO role at other listed Australian mining firms, per the filing.AnteoTech shares fell 8% in recent Friday trade.
AnteoTech (ASX:ADO) completed the initial stage of a collaborative immunoassay product development work program, according to a Wednesday Australian bourse filing.The program is focused on the development of AnteoBind NXT activated magnetic particles for chemiluminescent immunoassays (CLIA).The initial stage involved performance testing of the magnetic particles, supplied by an unnamed global life sciences company, for their suitability for use in large scale, high-throughput, automated CLIA diagnostic platforms.The next stage of work has been agreed and is about to begin, the company said.AnteoTech's shares jumped nearly 18% in recent trading on Wednesday.
AnteoTech (ASX:ADO) launched its new Anteo C primer coating product as another commercialization milestone for its Advanced Battery Technology business, according to a Tuesday Australian bourse filing.The company said Anteo C has progressed from laboratory-scale evaluation to manufacturing-scale process trials, with a 20-liter sample shipped to a South Korean manufacturer for evaluation.Anteo C is a new cross-linker performance additive used in primer coatings on copper foil anode and aluminum foil cathode current collectors in lithium-ion batteries, with additional global customer opportunities identified and engagement activities underway, it added.The company's shares rose 8% on market close.
AnteoTech (ASX:ADO) said Japanese life sciences distributor Cosmo Bio was appointed to supply AnteoBind and related products in Japan, effective immediately, according to a Thursday Australian bourse filing.Cosmo Bio will market and supply AnteoBind and related products to Japan for use in bioconjugation workflows within the in vitro diagnostics market, including research institutes and organisations developing and utilising immunoassays.The agreement is nonexclusive, carries an initial term of three years, and there are no minimum purchase obligations. The other terms of the agreement are confidential.Its shares jumped 14% in recent trading on Thursday, reaching an over two-year peak.
AnteoTech (ASX:ADO) signed a collaboration and sales agreement term sheet with South Korean separator technology firm Xerabrid, according to a Tuesday filing with the Australian bourse.The company's Anteo S cross-linking separator product will be combined with Xerabrid's ceramic coated separator technology in the formulation, development, testing and delivery of customer sales support across next generation battery separators to improve battery safety, the filing said.The two parties are expected to finalize a comprehensive three-year agreement within 120 days, per the filing.Financial terms of the deal were not disclosed.AnteoTech shares rose nearly 38% in morning trade Tuesday and earlier reached their highest since June 2023.
